- Home
- PSHG vs HIND Comparison
PSHG vs HIND Comparison
Compare PSHG & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSHG | HIND |
|---|---|---|
| Founded | 2010 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.8M | 28.0M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | PSHG | HIND |
|---|---|---|
| Price | $2.13 | $3.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 128.4K | N/A |
| Earning Date | 02-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $79,691,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $44.97 | N/A |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.31 | N/A |
| 52 Week High | $2.58 | N/A |
Technical Indicators
Market Signals| Indicator | PSHG | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 30.25 |
| Support Level | $2.01 | $3.62 |
| Resistance Level | $2.35 | $3.84 |
| Average True Range (ATR) | 0.11 | 0.27 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 28.55 | 5.45 |
Price Performance
Historical ComparisonAbout PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.
About HIND Vyome Holdings Inc.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.